Dr. Charles Prober, MD
Palo Alto, CA
46 Years of Experience
Who is Dr. Prober, Pediatric Infectious Diseases Specialist in Palo Alto, CA?
Dr. Charles Prober, MD is a Pediatric Infectious Diseases Specialist, who primarily practices in Palo Alto, CA. He has been practicing for over 46 years and is board certified. Dr. Prober completed his residency at Calif-Moffitt Hosp. Dr. Prober is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Prober’s office at (650) 497-8000.
Where did Dr. Prober go to medical school and complete their residency?
Fellowship: Stanford University School of Medicine, Stanford, CA | Stanford University School of Medicine CA
Residency: Calif-Moffitt Hosp | Children's Hospital, Winnipeg, Canada | University of California, San Francisco | Children's Hospital, Canada | University of Manitoba Affiliated Hospitals
Medical School: University of Manitoba Fac of Medicine
Is Dr. Prober board certified as a Pediatric Infectious Diseases Specialist?
Yes, Dr. Charles Prober, MD is board certified by the American Board of Pediatrics , American Board of Pediatrics since 1978
What languages does Dr. Prober speak?
Dr. Prober and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Pediatric Infectious Diseases Specialist like Dr. Prober typically treat?
As a Pediatric Infectious Diseases Specialist, conditions treated by Dr. Charles Prober may include:
Please contact Dr. Prober's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Pediatric Infectious Diseases Specialist like Dr. Prober typically perform?
As a Pediatric Infectious Diseases Specialist, procedures performed by Dr. Charles Prober may include:
- Epidemiology Consultation
- Epidemiology Follow Up
- HIV / AIDS Consultation
- HIV / AIDS Follow Up
- Human Papillomavirus (HPV) Vaccine
- Infection Follow Up
- Lumbar Puncture
- Pertussis Vaccine
Please contact Dr. Prober's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Prober accept my insurance?
Please contact Dr. Prober's office to confirm accepted insurance plans.
Where is Dr. Prober's office located?
Recognitions
Awards
Henry J. Kaiser Award for Preclinical Teaching, Stanford University Sc
The Harry Bain Award for Excellence in Clinical Teaching, The Hospita
Mayne Guest Professorship, Department of Child Health,
National Institutes of Health, Immunologic and Infectious Diseases Ac
Arthur L. Bloomfield Award for Teaching of Clinical Medicine, Stanfor
Henry J. Kaiser Award for Clinical Teaching, Stanford University Scho
Publications
Lecture halls without lectures--a proposal for medical education.
, 2012
Decisions, Decisions: How Program Diversity Influences Residency Program Choice
, 2011
Commentary: To Genotype or Not to Genotype? Addressing the Debate Through the Development of a
, 2011
Human Herpesvirus 6
, 2011
Principles & Practice of Pediatric Infectious Diseases
Treatment of turally acquired common colds with zinc: A structured review
, 2007
Effect of materl herpes simplex virus (HSV) serostatus and HSV type on risk of neotal herpes
, 2007
Materl herpes simplex virus antibody avidity and risk of neotal herpes
, 2006
Sixth disease and the ubiquity of human herpesviruses
, 2005
Herpesviridae infections in newborns: varicella zoster virus, herpes simplex virus
, 2004
New antivirals and antiviral resistance
, 2004
Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections.
, 2003
Congenital cytomegalovirus (CMV) infections: Hats off to Alabama
, 2003
Neotal herpes infection: diagnosis, treatment and prevention.
, 2002
Antiviral therapy for influenza virus infections.
, 2002
Prevention of hepatitis B in adolescents
, 2001
Pediatric uses of valacyclovir, penciclovir and famciclovir
, 2001
Antiviral agents effective against herpesviruses.
, 2001
Magement of the neote whose mother received suppressive acyclovir therapy during late pregncy
, 2001
Technical report: precautions regarding the use of aerosolized antibiotics. Committee on Infectious
, 2000
Advances in prevention of respiratory syncytial virus infections
, 1999
Possible association of intussusception with rotavirus vaccition. American Academy of Pediatrics.
, 1999
Posttraumatic invasive Aspergillus fumigatus wound infection
, 1999
Cephalosporins: an update.
, 1998
Encephalitis - Identifying the specific cause is key to effective magement
, 1998
Acyclovir therapy in a steroid recipient with varicella
, 1997
Herpes simplex virus type 2 - A persistent problem
, 1997
Genital herpes during pregncy: Ibility to distinguish primary and recurrent infections clinically
, 1997
Bacterial resistance and the dilemma of antibiotic usage
, 1997
Reducing the morbidity of lower respiratory tract infections caused by respiratory syncytial virus
, 1997
Application of the polymerase chain reaction to the diagnosis
, 1996
T cell recognition and cytokine production elicited by common and type
, 1996
Antibiotic update: Overview
, 1996
Pharmacokinetic optimisation of the treatment of septic arthritis
, 1996
Epidemiology of herpes simplex virus type 2 infections in a high-risk adolescent population
, 1996
Pediatric resident training in a school environment - A prescription for learning
, 1996
Early diagnosis and magement of herpes simplex encephalitis
, 1996
Herpesvirus infections of the vulva
, 1996
THE ROLE OF STEROIDS IN THE MAGEMENT OF CHILDREN WITH BACTERIAL-MENINGITIS
, 1995
ALYSIS OF THE EPIDEMIOLOGY AND PATHOGENESIS OF HERPES-SIMPLEX VIRUS
, 1993
CESAREAN DELIVERY FOR WOMEN PRESENTING WITH GENITAL HERPES LESIONS - EFFICACY, RISKS, AND COSTS
, 1993
FEVER AND INFECTION IN THE AGE SINCE WUNDERLICH
, 1993
HERPETIC VAGINITIS IN 1993
, 1993
Detection of antibodies to herpes simplex virus type 2 with a mammalian cell line expressing
, 1993
Neotal herpes: vexing dilemmas and reasons for hope.
, 1993
THE MAGEMENT OF PREGNCIES COMPLICATED BY GENITAL INFECTIONS WITH HERPES-SIMPLEX VIRUS
, 1992
IDENTIFICATION OF WOMEN AT UNSUSPECTED RISK OF PRIMARY INFECTION WITH HERPES-SIMPLEX VIRUS TYPE
, 1992
RESPIRATORY SYNCYTIAL VIRUS AND RIBAVIRIN - QUO-VADIS
, 1992
Acyclovir treatment of varicella
, 1992
PROPHYLACTIC FLUCOZOLE AND CANDIDA-KRUSEI INFECTIONS
, 1992
Herpes simplex virus infections: the genital tract and the newborn.
, 1992
CURRENT ANTIBIOTIC-THERAPY OF COMMUNITY
, 1992
POTENTIAL OF POPULATION PHARMACOKINETICS TO REDUCE THE FREQUENCY OF BLOOD
, 1992
Investigation of varicella
, 1992
MEDICAL-MAGEMENT OF NEWBORNS AND INFANTS BORN TO HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE MOTHERS
, 1991
A CONTROLLED TRIAL OF AEROSOLIZED RIBAVIRIN IN INFANTS RECEIVING MECHANICAL VENTILATION
, 1991
THE IMPACT OF RESPIRATORY VIRAL-INFECTIONS IN PATIENTS WITH CYSTIC-FIBROSIS
, 1991
PREDICTORS OF MORBIDITY AND MORTALITY IN NEOTES WITH HERPES-SIMPLEX VIRUS-INFECTIONS
, 1991
A CONTROLLED TRIAL COMPARING VIDARABINE WITH ACYCLOVIR IN NEOTAL HERPES-SIMPLEX VIRUS-INFECTION
, 1991
PHARMACOKINETICS OF ACYCLOVIR IN THE TERM HUMAN-PREGNCY AND NEOTE
, 1991
CRYPTOCOCCUS INFECTION IN A 9-YEAR
, 1991
THE RISK OF DEXAMETHASONE IN PREGNT-WOMEN WITH A HISTORY OF RECURRENT GENITAL HERPES
, 1991
CONSENSUS - VARICELLA-ZOSTER INFECTIONS IN PREGNCY AND THE PERITAL-PERIOD
, 1990
USE OF POLYMERASE CHAIN-REACTION FOR SUCCESSFUL IDENTIFICATION OF ASYMPTOMATIC GENITAL
, 1990
HERPES-SIMPLEX VIRUS-INFECTIONS
, 1990
GENTAMICIN PHARMACOKINETICS IN NEOTES UNDERGOING EXTRACORPOREAL MEMBRANE-OXYGETION
, 1990
A PROSPECTIVE EVALUATION OF PRIMARY GENITAL HERPES-SIMPLEX VIRUS TYPE
, 1990
THE USE OF ANTIBIOTICS IN NEOTES WEIGHING LESS THAN 1200 GRAMS
, 1990
NEOTAL ANTIBODY-DEPENDENT CELLULAR CYTO
, 1989
VANCOMYCIN PHARMACOKINETICS IN VERY LOW BIRTH-WEIGHT NEOTES
, 1989
Genital herpes and the pregnt woman.
, 1989
PHARMACOKINETICS AND ADVERSE-EFFECTS OF AMPHOTERICIN-B IN INFANTS AND CHILDREN
, 1988
USE OF ROUTINE VIRAL CULTURES AT DELIVERY TO IDENTIFY NEOTES EXPOSED TO HERPES-SIMPLEX VIRUS
, 1988
TYPE-SPECIFIC ANTIBODIES TO HERPES-SIMPLEX VIRUS TYPE-2 (HSV-2) GLYCOPROTEIN-G IN PREGNT-WOMEN
, 1988
RECURRENT URETHRITIS ASSOCIATED WITH UREAPLASMA-UREALYTICUM IN A PREPUBERTAL BOY
, 1987
PERITAL VIRAL-INFECTIONS
, 1987
FALSE POSITIVITY OF LEGIONELLA SEROLOGY IN PATIENTS WITH CYSTIC-FIBROSIS
, 1987
LOW-RISK OF HERPES-SIMPLEX VIRUS-INFECTIONS IN NEOTES EXPOSED TO THE VIRUS AT THE TIME OF VAGIL
, 1987
VANCOMYCIN PHARMACOKINETICS AND DOSE RECOMMENDATIONS FOR PRETERM INFANTS
, 1987
FAILURE OF ANTEPARTUM MATERL CULTURES TO PREDICT THE INFANTS RISK OF EXPOSURE TO HERPES
, 1986
RIFAMPIN ALONE OR WITH TRIMETHOPRIM FOR CONTACTS OF CHILDREN WITH HAEMOPHILUS-INFLUENZAE TYPE
, 1986
SEQUELAE OF ACUTE BACTERIAL-MENINGITIS IN CHILDREN TREATED FOR 7 DAYS
, 1986
THE VALUE OF SKIN BIOPSIES IN FEBRILE, NEUTROPENIC, IMMUNOCOMPROMISED CHILDREN
, 1986
PRIMARY OSTEOMYELITIS CAUSED BY COAGULASE-NEGATIVE STAPHYLOCOCCI
, 1986
AN UNUSUAL CASE OF INTRACRANIAL SUPPURATION
, 1985
DACTYLITIS IN A CHILD WITH SICKLE-CELL TRAIT
, 1985
EFFECT OF RIFAMPIN ON CHLORAMPHENICOL LEVELS
, 1985
BRAIN ABSCESSES IN INFANTS AND CHILDREN
, 1985
PERSISTENT FEVER AND SUBDURAL EFFUSIONS
, 1985
TREATMENT OF BACTERIAL-INFECTIONS IN THE NEOTE
, 1985
INVITRO INTERACTIONS BETWEEN RIFAMPIN AND AMPICILLIN OR CHLORAMPHENICOL AGAINST HEMOPHILUS
, 1984
AMINOGLYCOSIDE-RELATED NEPHROTOXICITY IN THE PREMATURE NEWBORN
, 1984
ASSOCIATION OF RESPIRATORY VIRAL-INFECTIONS WITH PULMORY DETERIORATION IN PATIENTS WITH CYSTIC
, 1984
SYSTEMIC TINEA VERSICOLOR, OR HOW FAR CAN FURFUR GO
, 1984
PROPHYLACTIC SULFAMETHOXAZOLE AND TRIMETHOPRIM IN VENTRICULOPERITONEAL SHUNT SURGERY - A DOUBLE
, 1984
SPUTUM BACTERIOLOGY IN PATIENTS WITH CYSTIC-FIBROSIS IN A TORONTO HOSPITAL DURING 1970-1981
, 1984
THE MAGEMENT OF CENTRAL INTRAVENOUS CATHETER INFECTIONS
, 1984
OPEN LUNG-BIOPSY IN IMMUNOCOMPROMISED CHILDREN WITH PULMORY-INFILTRATES
, 1984
PSEUDOMOS CEPACIA INFECTION IN CYSTIC-FIBROSIS - AN EMERGING PROBLEM
, 1984
AMIKACIN DOSES IN VERY LOW-BIRTH-WEIGHT NEWBORNS
, 1983
TOWARD OPTIMIZATION OF THERAPY IN THE NEOTE
, 1983
THE HIGH-PERFORMANCE LIQUID
, 1983
IMPACT OF CHLORAMPHENICOL USE ON BACTERIAL-RESISTANCE IN A NEOTAL INTENSIVE-CARE UNIT
, 1983
CEFOPERAZONE - A COMPARATIVE INVITRO CADIAN STUDY OF 1743 PATHOGENS
, 1983
MEASUREMENT OF AMPHOTERICIN-B IN SERUM OR PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
, 1983
Chloramphenicol in the newborn infant.
, 1983
VENTRICULAR CEREBROSPIL-FLUID CONCENTRATIONS OF TRIMETHOPRIM-SULFAMETHOXAZOLE
, 1983
CHLORAMPHENICOL PHARMACOKINETICS IN THE NEWBORN
, 1983
VARICELLA ZOSTER VIRUS
, 1983
IMMUNOLOGICAL RESPONSES OF CHILDREN TO SERIOUS INFECTIONS WITH STREPTOCOCCUS-PNEUMONIAE
, 1983
FEVER IN A NEWBORN
, 1982
HEMOPHILUS-INFLUENZAE TYPE-B IN A NURSERY-SCHOOL - THE VALUE OF BIOTYPING
, 1982
ORAL ANTIBIOTIC-THERAPY FOR BONE AND JOINT INFECTIONS
, 1982
ACYCLOVIR THERAPY OF CHICKENPOX IN IMMUNOSUPPRESSED CHILDREN - A COLLABORATIVE STUDY
, 1982
INITIATION OF CHLORAMPHENICOL THERAPY IN THE NEWBORN-INFANT
, 1982
PREVENTION OF TRANSFUSION-ACQUIRED CYTOMEGALO-VIRUS INFECTIONS IN NEWBORN-INFANTS
, 1981
SIDE-EFFECTS OF CLOXACILLIN IN INFANTS AND CHILDREN
, 1981
EIKENELLA-CORRODENS EMPYEMA IN CHILDREN
, 1981
THE EFFECT OF CHRONOLOGIC AGE ON THE SERUM CONCENTRATIONS OF AMIKACIN IN SICK TERM AND PREMATURE
, 1981
Antibiotic abuse: spare the child.
, 1980
COMPARISON OF A MICROMETHOD FOR PERFORMANCE OF THE SERUM BACTERICIDAL TEST WITH THE STANDARD TUBE
, 1979
USE OF THE SERUM BACTERICIDAL TITER TO ASSESS THE ADEQUACY OF ORAL ANTIBIOTIC
, 1979
WHITE CELL RATIO IN THE VERY LOW BIRTH-WEIGHT INFANT
, 1979
STORAGE AND TRANSPORT OF CULTURES FOR HERPES-SIMPLEX VIRUS, TYPE-2
, 1979
YERSINIA-PSEUDOTUBERCULOSIS SEPTICEMIA
, 1979
What is Dr. Prober's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Prober's National Provider Identifier (NPI) number is 1447385711.
What common questions do patients ask about Dr. Prober?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Prober
What is Dr. Charles Prober's specialty?
Dr. Prober is a Pediatric Infectious Diseases Specialist near Palo Alto, CA.
What does a Pediatric Infectious Diseases Specialist do?
A pediatrician trained in the diagnosis, treatment, and prevention of infectious diseases in children. This specialist utilizes their expertise to improve outcomes for pediatric infections, particularly those with complicated courses, underlying conditions that increase the risk of unusual or severe infections, ambiguous diagnoses, rare diseases, and complex or investigational treatments.
Is this Dr. Charles Prober affiliated with a ranked Castle Connolly Top Hospital?
No, Prober is not affiliated with a Castle Connolly Top Hospital, but is affiliated with the following hospitals: Stanford Medicine Children’s Health. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Pediatric Infectious Diseases Specialist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Pediatric Infectious Diseases Specialist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Charles Prober accepting new patients in Palo Alto, CA?
Yes, Dr. Charles Prober is accepting new patients at this time.
Does Dr. Charles Prober offer online booking?
Please contact Dr. Prober's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Charles Prober?
Please contact Dr. Prober's office at (650) 497-8000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Charles Prober have?
Dr. Charles Prober is certified by the American Board of Pediatrics.
Other Pediatric Infectious Diseases Specialist Near Palo Alto, CA
Pediatric Infectious Diseases Specialist
Accepting patientsPediatric Infectious Diseases Specialist
Accepting patientsPediatric Infectious Diseases Specialist
Accepting patients